Dose-effect and dose-response relationships for lead in children

The Journal of Pediatrics
|December 1, 1975
PubMed

Insights

Chelatable lead levels, not blood lead, better predict adverse effects on hemoglobin synthesis in children. Erythrocyte protoporphyrin is a practical indicator for monitoring lead poisoning risk.

Area of Science:

  • Toxicology
  • Environmental Health
  • Pediatrics

Background:

  • Lead absorption can cause serious health effects, particularly in children.
  • Understanding dose-effect and dose-response relationships is crucial for lead poisoning prevention.
  • Identifying the critical organ and critical effect guides early intervention strategies.

Purpose of the Study:

  • To re-examine lead absorption and prevention strategies using critical organ and clinical effect concepts.
  • To evaluate the predictive value of blood lead levels versus chelatable lead for adverse effects.
  • To assess the utility of dose-response relationships in understanding lead toxicity.

Main Methods:

  • Analysis of dose-effect and dose-response relationships in lead absorption.
  • Evaluation of blood lead values as predictors of critical effects.
  • Assessment of chelatable lead and its correlation with hemoglobin synthesis indicators.
  • Comparison of dose-response concepts with traditional screening test evaluations.

Main Results:

  • Blood lead levels (50-80 mug/dl) are poor predictors of critical effects in pediatric lead absorption.
  • Chelatable lead shows a significant linear relationship with critical effects on bone marrow hemoglobin synthesis.
  • Erythrocyte protoporphyrin, delta-aminolevulinic acid, and urinary coproporphyrin indicate these critical effects.
  • The dose-response concept offers a superior framework for understanding lead's adverse effects compared to sensitivity/specificity metrics.

Conclusions:

  • Chelatable lead is a more reliable indicator than blood lead for assessing lead's impact on hemoglobin synthesis.
  • Erythrocyte protoporphyrin is a practical biomarker for monitoring children at risk of lead poisoning (plumbism).
  • The dose-response model better accounts for individual variability in lead toxicity.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship01:14

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship01:23

Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship

Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates that even as drug...
Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...